Traitement en cours...
COMPANYPRODUCTS & SERVICESPARTNERSHIPSPRESS & EVENTSCONTACT
News & PressPublicationsAgendas
201220112010200820072006200520042003200220012000199919981997199619951994199319921991
Publications

2002

Decaudin, D., Castedo, M., Nemati, F., Beurdeley-Thomas, A., De Pinieux, G., Caron, A., Pouillart, P., Wijdenes, J., Rouillard, D., Kroemer, G., and Poupon, M.F. (2002). Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. Cancer Res 62, 1388-1393.

Boyer, B., Bourgeois, Y., and Poupon, M.F. (2002). Src kinase contributes to the metastatic spread of carcinoma cells. Oncogene 21, 2347-2356.

Magne, N., Fischel, J. L., Dubreuil, A., Formento, P., Poupon, M.F. Laurent-Puig, P., and Milano, G. (2002). Influence of epidermal growth factor receptor (EGFR), p53 and intrinsic MAP kinase pathway status of tumour cells on the antiproliferative effect of ZD1839 ("Iressa"). Br J Cancer 86, 1518-1523.

de Cremoux, P., Tran-Perennou, C., Elie, C., Boudou, E., Barbaroux, C., Poupon, M.F. De Rycke, Y., Asselain, B., and Magdelenat, H. (2002). Quantitation of estradiol receptors alpha and beta and progesterone receptors in human breast tumors by real-time reverse transcription-polymerase chain reaction. Correlation with protein assays. Biochem Pharmacol 64, 507-515.

dit Faute, M. A., Laurent, L., Ploton, D., Poupon, M.F., Jardillier, J. C., and Bobichon, H. (2002). Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant. Clin Exp Metastasis 19, 161-168.

Oudard, S., Levalois, C., Andrieu, J. M., Bougaran, J., Validire, P., Thiounn, N., Poupon, M.F., Fourme, E., and Chevillard, S. (2002). Expression of genes involved in chemoresistance, proliferation and apoptosis in clinical samples of renal cell carcinoma and correlation with clinical outcome. Anticancer Res 22, 121-128.

Sanceau, J., Poupon, M.F.., Delattre, O., Sastre-Garau, X., and Wietzerbin, J. (2002). Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide. Oncogene 21, 7700-7709.

April 22-25, 2013 | Chicago, IL | BIO International Convention
to know more
April 6-10, 2013 | Washington, DC | Annual AACR meeting
to know more
XenTech Acknowledged in Deloitte’s 2012 Technology Fast 500™ EMEA for 2nd Year Running
to know more
March 14-15, 2013 I Bologna, Italy I Stefano Cairo will be attending the SIOPEL group Spring Meeting
to know more
March 9th 2013 I Barcelona I Olivier Déas is giving a lecture at the CONPO symposium
to know more
March 7-9, 2013 | Barcelona, Spain | CONPO symposium
Breast, Colon, lung and Melanoma
to know more
Design by Ineiaki | Sitemap | Terms of use